Page 24 of 32 · 745 questions tagged clinical-trials.
Stated plainly: dulaglutide · cagrilintide. I suspect the honest answer is that it depends, in which case I would like to know on what. Assume I can obtain either…
The particulars: oral semaglutide · retatrutide. The comparison I want does not seem to exist anywhere in a form I can evaluate. I have read the arguments for each…
Setup, so nobody has to ask: SELECT · a GLP-1 receptor agonist. I have read the primary source rather than the summary, which has left me with more questions. I…
The particulars: semaglutide · FLOW. The empirical answer seems settled. The explanation does not. If the honest answer is that nobody knows, I would rather hear that…
The particulars: SURMOUNT-5 · nausea · 10 mg. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is that I…
What I have: SELECT · headache. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is that I am being…
I have three data points across nine months, which I hope is enough to see a trend. This should be a straightforward calculation and I keep getting two different…
I am reading the trial table rather than the press release, which is why the numbers differ. I want to understand what this actually establishes, as opposed to what…
My records go back to the first dose with dates, so I can reconstruct the timeline exactly. I have read the primary source rather than the summary, which has left me…
The case in front of me: twelve weeks · retatrutide. I would rather be corrected now than propagate something wrong. I am specifically not interested in a…
I am reading the trial table rather than the press release, which is why the numbers differ. I can do the algebra. I am not confident about the conversion factors. If…
What I am working with: constipation · a GLP-1 receptor agonist · SURPASS-3. I have read the primary source rather than the summary, which has left me with more…
This is a first order from this supplier, so I have no track record to reason from. The empirical answer seems settled. The explanation does not. If the honest answer…
Setup, so nobody has to ask: TRIUMPH-3 · a GLP-1 receptor agonist. I would like help reading this properly rather than being told what conclusion to reach. I have the…
Stated plainly: ecnoglutide · liraglutide. These are treated as interchangeable and I do not think they are. If both are acceptable I would like to know that, so I…
Stated plainly: SELECT · a GLP-1 receptor agonist. This has the shape of a fact but I cannot find its origin. What I found instead were three secondary sources all…
What I am working with: survodutide · retatrutide. I would like the axes of comparison first and the recommendation second. I have tried the first option and it…
The case in front of me: ecnoglutide · minus 20 °C. I want to know whether there is evidence behind this or only repetition. I have checked the obvious registries and…
What I have: a GLP-1 receptor agonist · 4 °C. I am asking for verification rather than opinion, ideally with something I can read myself. It is possible the evidence…
Stated plainly: early satiety · semaglutide · STEP 5. I would like help reading this properly rather than being told what conclusion to reach. I have the full report…
Concretely: SUSTAIN-6 · semaglutide. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the specifics…
What I have: mazdutide · 40 °C. I would rather be corrected now than propagate something wrong. I am specifically not interested in a testimonial; I am interested in…
Numbers first: STEP 8 · semaglutide. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to disagree,…
Details up front: a GLP-1 receptor agonist · 30 °C. I am asking for verification rather than opinion, ideally with something I can read myself. It is possible the…